Cypress Grove Rehab: Cancer Drug Left Unsupervised - IN

The resident at Cypress Grove Rehabilitation Center had exemestane 25 milligrams within arm's reach during a random inspection on April 6. The white round pill, marked with the number 111, treats malignant breast cancer by blocking estrogen production. She told inspectors she didn't know what medication it was.

Nobody had completed the required safety assessment.

Federal inspectors found the medication violation during routine surveillance at the Medwell Drive facility. The discovery raised immediate questions about medication security protocols for residents managing complex cancer treatments.

Resident 2, as identified in inspection records, had been diagnosed with malignant neoplasm of the upper-inner quadrant of her left breast. Her physician had prescribed the daily exemestane tablet since October 2023, nearly three years of continuous cancer treatment. Medical records showed she remained cognitively intact and could eat independently.

The facility's own policy, revised in January 2008, explicitly requires nurses to evaluate each resident through a formal Self-Administration of Medication Assessment form before allowing unsupervised access to medications. The policy states nurses must "approve each resident that self-administers medication to ensure safe and effective procedures are followed."

Director of Nursing confirmed during an April 9 interview that no such assessment had been completed for the resident. The admission came three days after inspectors discovered the medication cup during their morning rounds.

Exemestane belongs to a class of drugs called aromatase inhibitors, designed to reduce estrogen levels in postmenopausal women with hormone-receptor-positive breast cancer. The medication can cause serious side effects including bone loss, joint pain, and increased risk of fractures. Proper monitoring ensures patients receive therapeutic benefits while minimizing adverse reactions.

The inspection revealed a gap between written policy and actual practice. While Cypress Grove maintained detailed protocols for medication self-administration, staff had failed to implement basic safety measures for a resident handling cancer treatment drugs daily.

Indiana Administrative Code specifically mandates that nursing facilities complete proper assessments before allowing residents to manage their own medications. The regulation exists to prevent medication errors, missed doses, and potential drug interactions that could compromise patient safety.

The resident's cognitive status made the oversight particularly concerning. Her January assessment confirmed mental clarity and independence with basic activities like eating. These factors typically support self-medication privileges, but only after formal evaluation confirms the resident can safely manage complex drug regimens.

Inspection records show the facility provided exemestane through physician orders dating to October 2023. The three-year prescription history suggests ongoing cancer management requiring consistent medication adherence. Missing doses or taking medications incorrectly could potentially compromise treatment effectiveness.

The Administrator presented the facility's self-administration policy during the inspection, acknowledging the written requirements existed. However, the document's 2008 revision date raised questions about whether staff received current training on medication assessment procedures.

Federal inspectors classified the violation as causing minimal harm with potential for actual harm. The determination reflects that while no immediate injury occurred, the practice created unnecessary risk for a vulnerable cancer patient managing critical treatment medications.

Cypress Grove Rehabilitation Center is disputing the citation, according to inspection records. The facility has not publicly detailed its grounds for challenging the federal finding or outlined specific corrective measures.

The case highlights ongoing challenges in nursing home medication management, particularly for residents with complex medical conditions requiring specialized drug therapies. Cancer patients depend on precise medication timing and dosing to maintain treatment effectiveness while managing side effects.

The resident continues living at the facility while managing her breast cancer diagnosis and ongoing treatment needs.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Cypress Grove Rehabilitation Center from 2026-04-09 including all violations, facility responses, and corrective action plans.

Additional Resources

• View all inspection reports for Cypress Grove Rehabilitation Center
• Browse all IN nursing home inspections